Skip to main content

Table 5 Cox regression analysis for main study outcomes

From: Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

  Univariate Multivariablea
  HR (95% CI) P HR (95% CI) P
Cardiovascular Events, n (%)
 Cluster 1 1.85 [1.46–2.34] < .001 1.88 [1.48–2.38] < .001
Cluster 2 (Ref.)
 Cluster 3 2.82 [2.24–3.55] < .001 2.87 [2.27–3.62] < .001
All-cause death, n (%)
 Cluster 1 2.55 [2.03–3.21] < .001 2.50 [1.98–3.15] < .001
Cluster 2 (Ref.)
 Cluster 3 3.55 [2.83–4.46] < .001 3.42 [2.72–4.31] < .001
Composite outcome, n (%)
 Cluster 1 2.09 [1.74–2.51] < .001 2.09 [1.74–2.51] < .001
Cluster 2 (Ref.)
 Cluster 3 2.81 [2.34–3.37] < .001 2.79 [2.32–3.35] < .001
  1. Legend: aadjusted for type of AF, EHRA score, use of OAC. HR hazard ratio. For other acronyms, please see previous tables’ legends